Posted on 11/6/20
Merck Makes a $2.8 Billion Bet on an Experimental New Cancer Drug
One of America's largest pharmaceutical companies is about to get a little bigger. On Thursday, Merck (NYSE:MRK) agreed to acquire a privately held biotech start-up called . . .
Posted on 11/6/20
Teladoc Health: A Quantitative Valuation
SummaryTeladoc Health is rapidly growing revenue and operates in a growing sector of the economy.Combining with Livongo Health gives the company access to a larger addressable . . .
Posted on 11/6/20
Is Teladoc Health a Buy on the Pullback?
Digital health was a struggling industry prior to the coronavirus pandemic, but COVID-19 changed the game, pushing consumers and providers alike toward digital health solutions. Unsurprisingly, . . .
Posted on 11/6/20
Caladrius Biosciences Provides Corporate Update
BASKING RIDGE, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 11/6/20
CorMedix Provides Business Update
BERKELEY HEIGHTS, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the . . .
Posted on 11/6/20
Celldex Provides Corporate Update
HAMPTON, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2020. . . .
Posted on 11/5/20
BD Announces Fiscal Fourth Quarter And Full Year 2020 Results
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended . . .
Posted on 11/5/20
Cigna Reports Third Quarter 2020 Performance
Global health services company Cigna Corporation (NYSE: CI) today reported solid third quarter 2020 performance led by strong execution by its Evernorth segment."In these dynamic and . . .
Posted on 11/5/20
Esteemed Panel of National Experts to Lead Peer-to-Peer Healthcare Technology Security Symposium
Private event for healthcare cybersecurity executives comes amidst new cybercriminal threats to care providers CyberRisk Alliance (CRA), a business intelligence company serving the cybersecurity and information . . .
Posted on 11/5/20
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
WARREN, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, . . .
Posted on 11/5/20
Prestige Consumer Healthcare Reports Fiscal 2021 Second Quarter Results
TARRYTOWN, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended . . .
Posted on 11/5/20
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
WILLIAMSVILLE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm . . .
Posted on 11/5/20
Athenex Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporate Update
BUFFALO, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies . . .
Posted on 11/5/20
Axsome Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system . . .
Posted on 11/5/20
Outlook Therapeutics Secures $10 Million
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg
Posted on 11/5/20
Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new class of drugs based on targeted . . .
Posted on 11/5/20
VYNE Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
BRIDGEWATER, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced financial results for the third quarter ended September 30, 2020 and . . .
Posted on 11/5/20
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
EWING, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS), a pharmaceutical technology company, today reported financial and operating results for the third . . .
Posted on 11/5/20
Amicus Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
CRANBURY, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for . . .
Posted on 11/5/20
Here's What's Behind Bristol Myers Squibb's Huge Acquisitions
The pharmaceutical industry is famous for generating enormous profits with help from patent-protected exclusivity, but those protections don't last forever. In order to produce steadily growing . . .
Posted on 11/4/20
Rocket Pharmaceuticals Reports Third Quarter 2020 Financial Results
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today reports financial . . .
Posted on 11/4/20
Conversion Labs Close $15 Million Private Placement
NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has closed on approximately $14.5 . . .
Posted on 11/4/20
Protara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and . . .
Posted on 11/4/20
Teladoc and Livongo Demolished Expectations. So Why Are Their Stocks Down?
Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. While . . .
Posted on 11/4/20
Tabula Rasa HealthCare Reports Third Quarter 2020 Results
MOORESTOWN, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc.(Nasdaq:TRHC), a healthcare technology company advancing the field of medication safety, today reported financial results . . .
New York
